Norges Bank I Mab Transaction History

Norges Bank

$716 Trillion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.95 - $3.85 $1.11 Million - $1.45 Million	-375,713 Closed	0 $0
Q2 2022 Aug 14, 2023	BUY	$8.27 - $18.43 $3.11 Million - $6.92 Million	375,713 New	375,713 $4.25 Million
Q1 2022 May 12, 2023	BUY	$12.54 - $46.93 $3.38 Million - $12.6 Million	269,330 New	269,330 $4.37 Million
Q1 2022 May 09, 2022	SELL	$12.54 - $46.93 $1.04 Million - $3.9 Million	-83,197 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$45.28 - $74.5 $3.77 Million - $6.2 Million	83,197 New	83,197 $3.94 Million
Q3 2021 Nov 14, 2022	BUY	$57.18 - $84.43 $13.9 Million - $20.6 Million	243,894 New	243,894 $17.7 Million
Q3 2021 Nov 05, 2021	SELL	$57.18 - $84.43 $1.72 Million - $2.53 Million	-30,000 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$47.86 - $83.95 $1.44 Million - $2.52 Million	30,000 New	30,000 $2.52 Million
Q2 2021 Aug 10, 2021	SELL	$47.86 - $83.95 $1.44 Million - $2.52 Million	-30,000 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$44.38 - $63.97 $1.33 Million - $1.92 Million	30,000 New	30,000 $1.45 Million
Q1 2021 May 07, 2021	SELL	$44.38 - $63.97 $1.33 Million - $1.92 Million	-30,000 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$32.94 - $47.15 $988,199 - $1.41 Million	30,000 New	30,000 $1.42 Million
Q4 2020 Feb 10, 2021	SELL	$32.94 - $47.15 $988,199 - $1.41 Million	-30,000 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$27.46 - $47.03 $823,800 - $1.41 Million	30,000 New	30,000 $1.41 Million
Q3 2020 Nov 10, 2020	SELL	$27.46 - $47.03 $823,800 - $1.41 Million	-30,000 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$13.0 - $31.0 $390,000 - $930,000	30,000 New	30,000 $899,000
Q2 2020 Aug 07, 2020	SELL	$13.0 - $31.0 $390,000 - $930,000	-30,000 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$10.63 - $15.37 $318,900 - $461,100	30,000 New	30,000 $390,000

Others Institutions Holding IMAB

# of Institutions

Shares Held

15.5M

Call Options Held

56.4K

Put Options Held

5.8K

Hhlr Advisors, Ltd. Grand Cayman, E9

6.91M
Shares

$6.56 Million
0.2% of portfolio
Decheng Capital Management Iii (Cayman), LLC

4.17M
Shares

$3.96 Million
3.04% of portfolio
Boothbay Fund Management, LLC New York, NY

1.42M
Shares

$1.35 Million
0.05% of portfolio
Temasek Holdings (Private) LTD Singapore, U0

567K
Shares

$538,317
0.0% of portfolio
David A. Siegel Two Sigma Advisers, LP | New York, Ny

499K
Shares

$474,335
0.0% of portfolio

View Full List

About I-Mab

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $78.9M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

More about IMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account